CHI3L1 and obstructive sleep apnea syndrome: The results show a decrease in CHI3L1 levels after 4 months of full PAP treatment in severely obese OSA patients (BMI ≥ 35 kg/m2), but not in those less obese (BMI < 35 kg/m2).